Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Chronic Venous Occlusions Treatment Market
As per product, the chronic venous occlusions treatment market is classified into devices and drugs. The drugs segment is projected to exceed USD 4.6 billion by 2030. Various drugs are utilized in the diagnosis and therapy, including analgesics, antibiotics, anticoagulants, and so on. Antibiotics are highly preferred to treat ulcers and skin infections brought on by chronic venous insufficiency. Rising demand and increased knowledge of the extensive benefits of drugs for treating chronic venous insufficiency are majorly credited for the projected segment growth.
The chronic venous occlusions treatment market from the edema application segment is expected to surpass a valuation of USD 2.6 billion by 2030. In 2021, a report in the PLOS Global Public Health Journal reported the prevalence of edema in around 19% of the American geriatric population. The mounting prominence of the numerous advantages offered by the available treatment options for chronic venous occlusion in the diagnosis and treatment of edema is expected to accelerate market trends.
The industry is segregated in terms of end-use into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers segment accounted for 22% of the chronic venous occlusions treatment market revenue in 2021 and is expected to observe robust development over 2022-2030 due to the increasing consumer preference for ASCs for outpatient surgical procedures, quality care, cost-effectiveness, and shorter stays. The inclusion of novel treatment devices for venous ulcers, edema, DVT, and other conditions, and access to various treatments, are anticipated to foster segment value.
Asia Pacific chronic venous occlusions treatment market is forecast to depict a 6.5% CAGR from 2022 to 2030. Escalating occurrences of varicose veins among adults and early diagnosis of chronic venous illnesses are enhancing product penetration, thereby supplementing APAC industry growth. In 2021, Zee News reports estimated that around 10 million Indians have varicose veins. Moreover, facilitative initiatives by government agencies and NGOs are slated to fuel the industry expansion in APAC.